Skip to main content
Celltrion, Inc. (KRX:068270)
South Korea flag South Korea · Delayed Price · Currency is KRW
204,000
-8,500 (-4.00%)
At close: Mar 9, 2026

Celltrion Revenue

Celltrion had revenue of 1.03T KRW in the quarter ending September 30, 2025, with 16.67% growth. This brings the company's revenue in the last twelve months to 3.90T, up 35.45% year-over-year. In the year 2024, Celltrion had annual revenue of 3.56T with 63.45% growth.

Revenue (ttm)
3,895.99B
Revenue Growth
+35.45%
P/S Ratio
11.46
Revenue / Employee
1.45B
Employees
2,680
Market Cap
44.65T

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243,557.30B1,380.87B63.45%
Dec 31, 20232,176.43B-107.54B-4.71%
Dec 31, 20222,283.97B390.57B20.63%
Dec 31, 20211,893.40B44.29B2.39%
Dec 31, 20201,849.12B720.66B63.86%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,556.97B
ALTEOGEN 202.18B
SK Biopharmaceuticals 675.41B
LigaChem Biosciences 159.27B
HLB Co., Ltd. 80.73B
Peptron 6.19B
Voronoi 7.49B
OliX Pharmaceuticals 10.18B
Revenue Rankings

Celltrion News

More News